Stocks and Investing Stocks and Investing
Tue, February 7, 2023
[ 12:00 AM ] - United States, WOPRAI
Cody Acree Maintained (SWKS) at Strong Buy with Increased Target to $135 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Craig Hettenbach Maintained (SWKS) at Hold with Increased Target to $114 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Vijay Rakesh Maintained (SWKS) at Strong Buy and Held Target at $135 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Harlan Sur Maintained (SWKS) at Hold with Increased Target to $120 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Gary Mobley Maintained (SWKS) at Hold with Increased Target to $110 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Anthony Stoss Maintained (SWKS) at Strong Buy with Increased Target to $130 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Craig Ellis Maintained (SWKS) at Hold with Increased Target to $115 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Richard Sunderland Maintained (SWX) at Hold with Decreased Target to $75 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Omar Nokta Maintained (ZIM) at Hold with Decreased Target to $20 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Thomas Champion Maintained (ZG) at Hold with Increased Target to $40 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Taylor McGinnis Downgraded (ZI) to Hold and Decreased Target to $33 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Raimo Lenschow Maintained (ZI) at Buy with Decreased Target to $34 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Siti Panigrahi Maintained (ZI) at Strong Buy with Decreased Target to $36 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
David Hynes Maintained (ZI) at Strong Buy with Decreased Target to $35 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Turrin Maintained (ZI) at Buy with Decreased Target to $40 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Elizabeth Porter Maintained (ZI) at Buy with Decreased Target to $35 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Alex Zukin Reiterated (ZI) at Buy with Decreased Target to $30 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Thomas Champion Maintained (Z) at Hold with Increased Target to $40 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
David Turkaly Reiterated (ZBH) at Buy and Held Target at $145 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Louise Chen Reiterated (ACRS) at Buy and Held Target at $38 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Brian Dobson Maintained (BMTX) at Strong Buy with Decreased Target to $13 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Janine Stichter Initiated (BIRD) at Hold on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jon Tower Maintained (BJRI) at Hold with Increased Target to $35 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Andrew Wittmann Maintained (ACM) at Buy with Increased Target to $103 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Joseph Pantginis Reiterated (ATNM) at Strong Buy and Held Target at $53 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Salim Syed Reiterated (ATRA) at Strong Buy and Held Target at $775 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Ami Fadia Reiterated (AVDL) at Strong Buy and Held Target at $11 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Oren Livnat Reiterated (AVDL) at Strong Buy and Held Target at $13 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Edward Tenthoff Maintained (ARWR) at Buy with Decreased Target to $52 on, Feb 7th, 2023
[ 12:00 AM ] - United States, WOPRAI
Joel Beatty Maintained (ARWR) at Buy with Decreased Target to $58 on, Feb 7th, 2023

Joel Beatty Maintained (ARWR) at Buy with Decreased Target to $58 on, Feb 7th, 2023


Published on 2024-10-28 01:24:51 - WOPRAI, Joel Beatty
  Print publication without navigation


Joel Beatty of Baird, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy with Decreased Target from $60 to $58 on, Feb 7th, 2023.

Joel has made no other calls on ARWR in the last 4 months.



There are 5 other peers that have a rating on ARWR. Out of the 5 peers that are also analyzing ARWR, 2 agree with Joel's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Andrew Galler of "Morgan Stanley" Maintained at Hold with Decreased Target to $37 on, Tuesday, November 29th, 2022
  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $31 on, Tuesday, November 29th, 2022


These are the ratings of the 3 analyists that currently disagree with Joel

  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $90 on, Tuesday, December 6th, 2022
  • Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $59 on, Wednesday, November 30th, 2022
  • Maury Raycroft of "Jefferies" Maintained at Strong Buy with Decreased Target to $75 on, Tuesday, November 29th, 2022

Contributing Sources